NCT00540410 - Cohort Study in Senegal Comparing Artesunate + Amiodaquine in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks | Biotech Hunter

Enrollment

366

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions

Malaria

Interventions

DRUG

Coarsucam® (artésunate (AS) + amodiaquine (AQ) as fixed dose combination)

Infants tablets: AS 25/AQ 67,5 mg Toddlers tablets: AS 50/AQ 135 mg Once daily, dose according to bodyweight range Duration of treatment: 3days Children tablets: AS 100/AQ 270 mg

DRUG

Coartem® (arthemether+ lumefantrine)

"Tablets, 20/120 mg, oral route, twice daily, dose according to bodyweight range.~Duration of treatment: 3 days"

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Dakar